HelpAcademyLoginJoin us as a Member

Catalyst Explorer

PDUFA dates, advisory committees, data readouts, conference presentations and filings. Every date links to its source.

Upcoming catalysts

Sign in to save as alertSign in to download .ics

Save as alert tells you about new catalysts for a watchlist. Phase, modality, designation, dates and keyword are not part of alert rules.

Columns: standard view
Columns for the table and the CSV

Every row keeps its source link and licence. Up to 40 columns; CT-VCA columns follow your plan.

Saved screens

Sign in to save these filters, columns and sort as a screen.

CSV export is part of Pro

Showing the next 30 days. Pro shows every date.

1 Nov 2026 to 1 Dec 2026, US Eastern dates. Compare plans

Catalysts, date, soonest first
Date Asset VerticalCatalystStageDesignationsCT-VCAFDA IQSource
, 29 days left in the periodCemdisiranREGENERON PHARMACEUTICALS, INC. (REGN) Sign in to set an alert for CemdisiranDrugPDUFAFiledPriority ReviewNo published CT-VCA scoreOff0000872589-26-000023 (opens in a new tab)
, 13 days to goBXCL501Not yet reviewed: Listed from FDA or ClinicalTrials.gov records; an editor has not checked it yetBioXcel Therapeutics, Inc. (BTAIQ) Sign in to set an alert for BXCL501DrugPDUFAPhase 3–No published CT-VCA scoreOff0001104659-26-061773 (opens in a new tab)
, 13 days to goIvonescimabNot yet reviewed: Listed from FDA or ClinicalTrials.gov records; an editor has not checked it yetSummit Therapeutics Inc. (SMMT) Sign in to set an alert for IvonescimabDrugPDUFAPhase 3–No published CT-VCA scoreOff0001599298-26-000006 (opens in a new tab)
, 29 days to goPovetaciceptVERTEX PHARMACEUTICALS INC (VRTX) Sign in to set an alert for PovetaciceptDrugPDUFAFiledFast TrackOrphanAccelerated ApprovalNo published CT-VCA scoreOff0000875320-26-000256 (opens in a new tab)

Countdowns use US Eastern dates. Dates come from company and FDA disclosures and can change. Every row links to its source. Nothing here is investment advice.